💊 Arzneimittel A-Z 🧬 Targets 🛠 Werkzeuge 📚 Leitfäden

Alle Arzneimittel Arzneimittelklassen Therapeutische Bereiche Nebenwirkungen

Leitfäden Glossar Zeitleiste

Vergleiche Arzneimittelreisen Arzneimittel-Wirkstoffgruppen

🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

EGFR (Epidermal Growth Factor Receptor)

EGFR

Receptor tyrosine kinase driving cell proliferation, commonly mutated in NSCLC.

Funktion

Activating mutations drive oncogenic signaling. Targeted by TKIs (erlotinib, osimertinib) and antibodies (cetuximab).

Related Targets

CDK4/CDK6 (Cyclin-Dependent Kinase 4/6) CDK4/CDK6 MTOR (Mechanistic Target of Rapamycin) MTOR BRAF (BRAF Kinase) BRAF BCR-ABL1 (BCR-ABL Fusion Protein) BCR-ABL1 KDR (Vascular Endothelial Growth Factor Receptor 2) KDR ALK (Anaplastic Lymphoma Kinase) ALK